CSIMarket
 
Accolade Inc   (NASDAQ: ACCD)
Other Ticker:  
 
    Sector  Services    Industry Professional Services
   Industry Professional Services
   Sector  Services
 
Price: $6.8900 $0.00 0.000%
Day's High: $6.91 Week Perf: 0.00
Day's Low: $ 6.89 30 Day Perf: 97.99 %
Volume (M): 722 52 Wk High: $ 13.93
Volume (M$): $ 4,977 52 Wk Avg: $6.10
Open: $6.90 52 Wk Low: $3.08



 Market Capitalization (Millions $) 556
 Shares Outstanding (Millions) 81
 Employees 1,788
 Revenues (TTM) (Millions $) 447
 Net Income (TTM) (Millions $) -180
 Cash Flow (TTM) (Millions $) -44
 Capital Exp. (TTM) (Millions $) 6

Accolade Inc
Accolade Inc is a US-based healthcare technology company that provides personalized healthcare assistance to individuals and employees of various corporations. Founded in 2007, Accolade has established itself as a leader in providing technology-enabled healthcare solutions that improve patient outcomes and reduce healthcare costs.

The company's main objective is to provide personalized, proactive support and advocacy to its clients, which helps them navigate the complexities of the healthcare system in order to obtain optimal outcomes. To achieve this, Accolade has developed a platform that integrates various healthcare data sources to provide a complete view of each patient's healthcare history.

The company's services are primarily targeted at two groups: individuals and employees. For individuals, Accolade provides support to help them find the right doctors, schedule appointments, and manage chronic conditions. For employees, Accolade partners with corporations to provide personalized healthcare support to their employees, which helps the employees manage their health and wellness, leading to reduced absenteeism, increased productivity, and lower healthcare costs.

Accolade's solution is designed to be scalable, flexible, and easy to integrate with existing healthcare systems. It uses advanced analytics and machine learning algorithms to identify individuals who are at risk of developing chronic conditions or requiring hospitalization. By intervening early, Accolade can help prevent these conditions from worsening, which leads to lower healthcare costs for patients and employers.

In addition to its core services, Accolade also offers a range of custom solutions for employers, including integration with existing wellness and employee assistance programs, as well as customized communications and marketing materials to promote healthcare education and awareness.

Accolade has received numerous awards and recognitions for its innovative approach to healthcare, including being named one of the "World's Most Innovative Companies" by Fast Company and the "Top AI-Powered Healthcare Company" by Forbes. The company has also raised over $500 million in funding from investors, including Andreessen Horowitz and GV (Google Ventures).

Overall, Accolade is a leading healthcare technology company that is helping individuals and corporations navigate the complexities of the healthcare system to achieve better patient outcomes and lower healthcare costs. Its innovative platform and personalized, proactive approach make it an ideal partner for healthcare providers and employers looking to improve their healthcare offerings.


   Company Address: 1201 Third Avenue Seattle 98101 WA
   Company Phone Number: 926-8100   Stock Exchange / Ticker: NASDAQ ACCD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Merger and Acquisition

Transcarents Strategic Acquisition of Accolade: A Game-Changer in Consumer-Centric Healthcare Solutions

Published Wed, Jan 8 2025 1:30 PM UTC

In a significant move poised to reshape the healthcare technology landscape, Transcarent has announced its acquisition of Accolade Inc., a pioneering company known for its personalized advocacy in healthcare. This merger seeks to consolidate resources and enhance their shared objective of consumer empowerment in an increasingly complex healthcare environment. Together, the n...

Stocks on the Move

Accolade Inc Faces Challenges amidst Strike, Investigations, and Acquisitions

Published Mon, Jul 22 2024 7:16 PM UTC

Throughout the month, Accolade Inc has experienced a decline in the performance of its shares compared to the overall market. This article will cover various news events that have contributed to the company s recent struggles, including a strike in Ontario, investigations into potential securities fraud, new talent emerging in the music industry, environmental recognition, a...

Stocks on the Move

Accolade Inc Behind the Market Performance Lag and Unrelated Accolades

Published Fri, Jul 12 2024 5:07 PM UTC

Accolade Inc Lagging behind the Market Performance: A Closer Look at Recent DevelopmentsThroughout this month, Accolade Inc shares have been underperforming, trailing the overall market performance. Year to date, Accolade Inc shares have also fallen behind, showing a decline of 18.79% compared to the market s performance. In order to understand the reasons behind this trend,...

Stocks on the Move

Accolade Inc Shares Struggle to Keep Pace with Market, Despite Noteworthy Achievements

Published Thu, Jul 11 2024 5:20 AM UTC

Accolade Inc Shares Continue to Trail Market PerformanceAccolade Inc shares have experienced a significant decline in recent weeks, as they continue to underperform the market. Despite achieving notable accomplishments in various industries, including aviation, retail, and automation services, the company s stock value has taken a hit. As of now, Accolade Inc s market capita...

Stocks on the Move

Accolade Inc Navigating Market Challenges and Operational Struggles

Published Fri, Jul 5 2024 6:55 PM UTC

Accolade Inc, a leading provider of healthcare technology solutions, has had a challenging year so far in terms of stock performance and financial outlook. The company s shares have lagged behind the overall market, signaling concerns for investors. Additionally, Accolade Inc has faced criticism and warnings from analysts regarding its financial standing. This article will a...







Accolade Inc's Segments
Access fees    67.92 % of total Revenue
Usage-based fees    32.08 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com